INS and metabolic syndrome: Growing evidence suggests that insulin and leptin play significant physiological roles in cognition (Paz-Filho et al., 2008; Morrison, 2009; Gray et al., 2014; Arnold et al., 2018), and these signaling pathways may be promising therapeutic targets to alleviate cognitive impairment accompanied by obesity and MetS (Mejido et al., 2020).